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nasal bone and maternal age for detection of fetal
chromosomal disorders in a high-risk population*
Estudo da translucência nucal, ducto venoso, osso nasal e idade materna na detecção
de cromossomopatia fetal em uma população de risco
Antonio Carlos Vieira Lopes1, Kleber Pimentel2, Maria Betânia Pereira Toralles3, Alessandro
de Moura Almeida4, Luciana Vieira Lopes5, Edward Araújo Júnior6, Luciano Marcondes Machado
Nardozza7, Antonio Fernandes Moron8
OBJECTIVE: To evaluate fetal nuchal translucency, ductus venosus, nasal bone and maternal age  ≥ 35 years
by means of aneuploidy screening between the 12th and 14th gestational weeks in a high-risk population.
MATERIALS AND METHODS: Prospective, observational study involving 92 pregnant women at 12–14
gestational weeks, who were submitted to chorionic villus sampling because of high risk for trisomy 21 based
on the measurement of nuchal translucency thickness (17.4%) or on maternal age ≥ 35 years (78.3%). Before
the chorionic villus sampling, fetal nuchal translucency thickness was measured, ductus venosus flow was
evaluated and the nasal bone was identified. Sensitivity, specificity, positive predictive value and negative
predictive value were calculated for tests in parallel and in sequence. RESULTS: Chromosomal abnormalities
were found in 12 fetuses (13.5%); 7 (58.3%) were positive for trisomy 21. The nasal bone was present in
all cases with chromosomal abnormalities. Isolated nuchal translucency, ductus venosus or maternal age
showed low sensitivity (41.67–58.33%) and low positive predictive value (10–45.45%). Combined nuchal
translucency + ductus venosus + maternal age showed the best results (100% sensitivity; 6.49% specificity;
14.29% positive predictive value; 100% negative predictive value). CONCLUSION: In pregnant women with
≥ 35 years of age, combined nuchal translucency + ductus venosus have showed the highest sensitivity as
an indication for invasive procedure.
Keywords: Nuchal translucency measurement; Ductus venosus; Nasal bone; Maternal age; Trisomy.
OBJETIVO: Avaliar a translucência nucal, o ducto venoso, o osso nasal e a idade materna ≥ 35 anos como
testes de rastreamento para aneuploidias entre 12 e 14 semanas de gestação em pacientes de alto risco.
MATERIAIS E MÉTODOS: Estudo prospectivo observacional envolvendo 92 gestantes entre 12 e 14 sema-
nas submetidas a biópsia de vilo corial por alto risco de trissomia, baseado na medida da translucência nucal
(17,4%) e idade materna ≥ 35 anos (78,3%). Antes da biópsia de vilo corial, realizaram-se medida da trans-
lucência nucal, avaliação de fluxo no ducto venoso e identificação do osso nasal. Calcularam-se a sensibi-
lidade, a especificidade, o valor preditivo positivo e o valor preditivo negativo para testes realizados em paralelo
e em seqüência. RESULTADOS: Encontrou-se alteração cromossômica em 12 (13,5%) fetos; 7 (58,3%)
apresentavam trissomia 21. Osso nasal foi identificado em todos os fetos com trissomia. Translucência nucal,
ducto venoso e idade materna isolados mostraram baixa sensibilidade (41,67–58,33%) e baixo valor predi-
tivo positivo (10–45,45%). A associação translucência nucal + ducto venoso + idade materna apresentou
o melhor resultado (sensibilidade: 100%; especificidade: 6,49%; valor preditivo positivo: 14,29%; valor
preditivo negayivo: 100%). CONCLUSÃO: Em gestantes com idade ≥ 35 anos, a associação translucência
nucal + ducto venoso mostra-se como a mais sensível para a indicação de procedimento invasivo.
Unitermos: Medição da translucência nucal; Ducto venoso; Osso nasal; Idade materna; Trissomia.
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INTRODUCTION
In 1866, Langdon Down observed that,
in individuals with trisomy 21, the skin
seemed to be redundant for the body, the
nose was small and the face was flat(1).
During the last years, several studies
have proposed non-invasive techniques for
the prenatal diagnosis of chromosomal
abnormalities based on both sonographic
findings and maternal biochemical tests.
Randomized studies have demonstrated
that invasive studies for karyotype re-
search, such as amniocentesis and chori-
onic villus sampling, present a risk for
miscarriage around 1%(2,3).
In Brazil, maternal biochemical tests are
restricted to few private and high-cost
health centers, so ultrasonography remains
as the main method for screening chromo-
somal abnormalities.
Advanced maternal age (MA) repre-
sents a risk factor for chromosomal abnor-
malities (trisomies 13, 18 and 21). Consid-
ering the high incidence of intrauterine
death of fetuses with chromosomal abnor-
malities, the risk decreases with the pro-
gression of the gestational age(4,5).
Nuchal translucency (NT) consists of a
hypoechoic sonographic image resulting
from accumulation of fluid behind the neck
of a fetus, occurring more exuberantly be-
tween the 10th and 14th weeks of gesta-
tion(6). Since early nineties, several studies
have reported the association between
nuchal translucency thickness and the pres-
ence of chromosomal abnormalities(7,8).
Early fetal cardiac failure has been pro-
posed as a possible mechanism for increase
in the NT thickness(9). Therefore, the evalu-
ation of the ductus venosus (DV) flow pat-
tern may reflect this hemodynamic status.
Studies in the literature report that alter-
ations in the DV flow pattern (absent or
reverse flow) present a high sensitivity with
low rate of false-positive results in the de-
tection of chromosomal abnormalities(10).
Also, the presence of an abnormal ductus
venosus flow pattern in a fetus with in-
creased NT thickness increased the risk for
chromosomal abnormality(11).
Several studies have demonstrated high
association between absence of nasal bone
(NB) observed in the gestational period
between 11 and 13 weeks and six days, and
trisomy 21(12–14). A recent study has dem-
onstrated that the association between NB
evaluation, DV flow pattern and NT thick-
ness in fetuses with high risk for chromo-
somal abnormalities presents a potential to
increase in 2% to 4% the sensitivity of the
screening for trisomy 21, or to decrease the
false-positive rate in 50%(15).
The present study is aimed at evaluat-
ing the significance of MA≥ 35 years, NT
thickness, NB evaluation and DV flow
pattern in a population of fetuses with high
risk for chromosomal abnormalities in the
period between 12 and 14 gestational
weeks for determining which test or tests
combination presents the highest associa-
tion with chromosomal abnormalities.
MATERIALS AND METHODS
The present prospective, observational
study was developed during the period
between January 2002 and September
2004, with 92 pregnant women between
their 12 and 14 gestational weeks, who had
been referred to the institution for fetal
karyotype study.
All of these patients agreed to partici-
pate in the present study whose previous
approval was granted by the Committee for
Ethics in Research of the Institution. The
procedures were performed in the Clínica
Dr. Antonio Carlos Vieira Lopes, recog-
nized as a reference in fetal medicine in the
state of Bahia, and in the Maternidade
Climério de Oliveira da Universidade Fed-
eral da Bahia (UFBA).
The chorionic villus samplings for
karyotype study were performed by a single
investigator by means of transabdominal
chorionic villus biopsy. The banding G
technique and polymerase chain reaction
for chromosomes 13, 16, 18, 21, 22, X and
Y(17) were utilized in the cytogenetic analy-
sis(16).
Criteria adopted for indication of chori-
onic villus sampling were increase in the
NT thickness (risk > 1.300) or MA > 35
years.
The abdominal approach was adopted
in the sonographic studies performed in an
Aloka model SSD-2000 equipment
coupled with a convex, multifrequential
transducer (3.5–5.0 MHz) by two experi-
enced sonographists for evaluating mark-
ers of chromosomopathies at the first tri-
mester of gestation.
The following sonographic views were
utilized for evaluation of the NT thickness:
sagittal view of the fetus, the same utilized
for the crown-rump length between 45 mm
and 84 mm; fetus in neutral position; fetal
image occupying at least 75% of the vis-
ible screen, calipers placed within the
anechoic space between the fetal skin and
the subcutaneous tissue overlying the cer-
vical spine. Three measurements were per-
formed for each of the fetuses, and the
highest value was considered for the pur-
poses of the present study.
Initially, color Doppler was utilized for
determining the localization of the vessel,
in the DV flow pattern evaluation. The DV
flow velocity waveforms were obtained on
a mid-sagittal plane of the fetal trunk at
< 30° insonation angle, immediately distal
to the portal sinus and proximal to the in-
fundibulum of the inferior vena cava. Such
a technique avoids the contamination of the
flow originating from the intrahepatic por-
tion of the umbilical vein, left hepatic vein
and inferior vena cava. The DV flow wave-
forms were classified as normal (positive
flow) or abnormal (absent or reverse flow),
according to the blood flow patterns dur-
ing the atrial contraction period.
In the NB evaluation, a mid-sagittal
view of the fetal face was acquired, with
the fetal dorsum posteriorly positioned
and a slight head flexion. Two echogenic
lines of the fetal nose profile should be vi-
sualized: the superficial echogenic line cor-
responding to the fetal skin, and the deeper
echogenic line corresponding to the NB.
The result of a technically satisfactory
study where the NB is visualized is classi-
fied as present NB. If the NB cannot be
visualized, the result is classified as absent
NB.
Data were recorded on an Excel work-
sheet (Microsoft, Windows XP) and ana-
lyzed by means of a statistical software
(SPSS 9.0 for Windows – SPSS Inc., Chi-
cago, Ill., USA). For continuous variables,
mean and standard deviation were calcu-
lated, and for categorical variables, the
percentage was calculated.
Aiming at determining the diagnostic
accuracy of the tests, sensitivity, specific-
ity, positive predictive value and negative
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Table 1 Evaluation of sensitivity, specificity, positive predictive value and negative predictive value of NT, DV and MA ≥ 35 years in the detection of chromo-
somal abnormalities in 89 patients submitted to chorionic villus sampling.
Test
NT
DV
MA ≥ 35 anos
Sensitivity (95 CI%)
58.3% (27.7–84.8%)
41.7% (15.2–72.3%)
58.3% (27.7–84.8%)
Specificity (95 CI%)
83.1% (72.9–90.7%)
92% (83.4–97.0%)
22.1% (13.4–33.0%)
Positive predictive value (95 CI%)
35% (15.4–59.2%)
45.45% (16.7–76.6%)
10.4% (4.3–20.3%)
Negative predictive value (95 CI%)
92.7% (83.9–97.6%)
90.79% (81.9–96.2%)
77.3% (54.6–92.2%)
NT, nuchal translucency; DV, ductus venosus; MA, maternal age; CI, confidence interval.
Table 2 Parallel and sequential evaluation of sensitivity, specificity, positive predictive value and nega-
tive predictive value of NT and DV in the detection of chromosomal anomalies in 89 patients submitted
to chorionic villus sampling.
Combined NT + DV
Sensitivity (95 CI%)
Specificity (95 CI%)
Positive predictive value (95 CI%)
Negative predictive value (95 CI%)
Parallel tests
66.7% (34.9–90.1%)
81.6% (71.0–89.5%)
14.3% (7.6–23.6%)
100.0% (47.8–100%
Sequential tests
33.3% (9.9–65.1%)
93.4% (85.3 –97.8%)
50.0% (1.3–98.7%)
87.4% (78.5–93.5%)
NT, nuchal translucency; DV, ductus venosus; CI, confidence interval.
Table 3 Parallel and sequential evaluation of sensitivity, specificity, positive predictive value and nega-
tive predictive value of NT, DV and MA ≥ 35 years in the detection of chromosomal anomalies in 89 patients
submitted to chorionic villus sampling.
Combined NT + DV + MA ≥ 35 years
Sensitivity (95 CI%)
Specificity (95 CI%)
Positive predictive value (95 CI%)
Negative predictive value (95 CI%)
Parallel tests
100% (73.5–100%)
6.5% (2.1–14.5%)
14.3% (7.6–23.6%)
100% (47.8–100%)
Sequential tests
8.3%(0.2–38.5%)
98.7% (93.0–100%)
50.0% (1.3–98.7%)
87.4% (78.5–93.5%)
NT, nuchal translucency; DV, ductus venosus; MA, maternal age; CI, confidence interval.
predictive value were calculated, with 95%
confidence interval (95% CI). The diagnos-
tic tests were evaluated alone, sequentially
and in parallel.
RESULTS
Cellular growth was not observed in
three of the 92 pregnant women submitted
to chorionic villus biopsy. These three cases
were excluded from the study.
In the remaining 89 pregnant women
evaluated for fetal karyotype, chromosomal
abnormality was found in 12 fetuses
(13.5%), seven of them (58.3%) with tri-
somy 21, one (8.3%) with trisomy 18, one
(8.3%) with trisomy 22, two (16.6%) with
47 XXY, and one (8.3%) with chromo-
somal marker 46 XY inv (9) (gh).
MA ranged between 25 and 47 years
(mean = 36.2 years – standard deviation =
4.6).Of the 89 pregnant women, 67
(75.3%) presented ages = 35 years, and 22
(24.7%) presented ages < 35 years. The
gestational age at the time of the chorionic
villus sampling ranged between 12 and 14
weeks (mean = 13 weeks – standard devia-
tion = 0.79).
The main indication for chorionic vil-
lus sampling was MA ≥ 35 years in 72 preg-
nant women (78.3%), followed by high risk
for trisomy 21 (> 1:300); based on the NT
thickness in 16 pregnant women (17.4%);
other reasons, such as previous history of
children with genetic diseases; previous
history of malformations in children, find-
ings of fetal morphological alterations at
ultrasound studies, represented 4.3% of the
indications for chorionic villus sampling.
NT measurement could be performed in
all of the cases, only by transabdominal
approach.
DV flow evaluation also could be per-
formed in all of the cases. The altered flow
ratio (absent or reverse waveform A) cor-
responded to 6:77 normal fetuses (7.8%).
In the group of fetuses with chromosomo-
pathies, this ratio was 5:12 fetuses (41.7%).
The evaluation of the NB could be per-
formed in all of the cases, with the NB
being present in the whole sample, both in
normal fetuses and those with chromo-
somal alterations.
Table 1 shows the sensitivity, specific-
ity, positive predictive value and negative
predictive value of NT, DV and MA alone
in the detection of chromosomal abnor-
malities.
Table 2 shows a parallel and sequential
evaluation of sensitivity, specificity, posi-
tive predictive value and negative predic-
tive value of combined NT/DV in the de-
tection of chromosomal abnormalities.
Table 3 shows a parallel and sequential
evaluation of sensitivity, specificity, posi-
tive predictive value and negative predic-
tive value of combined NT + DV + MA in
the detection of chromosomal abnormali-
ties.
DISCUSSION
The risk for many chromosomal abnor-
malities increases with the MA, however,
considering that fetuses with chromosomal
abnormalities present more frequent intrau-
terine death, the risk decreases with the
gestational age progression(4,5,18). The MA
has been the first marker adopted as a
method of screening for trisomy 21, with
30% detection rate, and 5% rate of false-
positive results(19). Snijders et al.(4) have
evaluated 57614 pregnant women with ≥ 35
years of age, between 9 and 16 weeks of
gestation, and reported 538 fetuses with
trisomy 21. They have observed that the
risk for trisomy 21 increases with the MA
and decreases with the gestational age. The
trisomy 21 prevalence in the period be-
tween 12 and 16 gestational weeks was of
30%, whereas with 40 weeks the preva-
lence decreases to 21%. In the present
study, the utilization of the MA alone as a
diagnostic test for chromosomal abnor-
malities presented low sensitivity (58.33%),
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with low positive predictive value (10.45%),
demonstrating its low significance in the
screening, when utilized alone.
NT has been firstly described by
Nicolaides et al.(6) as the screening for
fluid collection in the fetal nucha. It is im-
portant to note that this accumulation of
fluid found in the period between 11 and
14 gestational weeks is present in 75% of
fetuses with trisomies 18 and 21. Later,
several prospective studies have evidenced
the association between the increase in the
NT thickness and trisomy 21, with detec-
tion rates ranging between 58.3% and
100%(20–23), and false-positive rates around
5%. NT, likewise MA, presented a mild
sensitivity (58.33%) and low positive pre-
dictive value (35%). A possible explana-
tion for the low sensitivity might be the
small number of cases with chromosomal
abnormalities evaluated, a result compat-
ible with most of preliminary studies(24–26).
Utilizing ≥ 3 mm as cutoff value for NT
thickness, the rate of detection for chromo-
somal abnormalities ranged from 17.6% to
48.4%(24–26).
Another study has demonstrated that the
inclusion of the DV flow pattern in com-
bination with MA and NT thickness, be-
tween 10 and 16 gestational weeks, may
reduce the false positive rate in the screen-
ing for chromosomal abnormalities(27). In
the present study, the utilization of DV flow
pattern alone presented a sensitivity of only
41.67% in the detection of chromosomal
abnormalities. In the literature, no consen-
sus is found regarding the significance of
the utilization of DV flow pattern in the
detection of chromosomal abnormalities at
the first trimester of gestation, with sensi-
tivity ranging between 65% and 93,1%(10,27).
Antolín et al.(27) have evaluated 1371 low-
risk pregnant women in the period between
10 and 16 gestational weeks, utilizing the
NT thickness and DV flow pattern in the
screening for chromosomal abnormalities.
DV flow pattern alone presented a global
detection rate of 65%, with a false-positive
rate of 4.3%. Murta et al.(10) have evaluated
372 low-risk 10–14-week-old fetuses, find-
ing 29 with chromosomal abnormalities.
DV flow pattern was altered (zero or re-
verse waveform A) in 93.1% of fetuses
with chromosomal abnormalities and in
only 1.7% of normal fetuses.
As regards the NB evaluation, several
studies have demonstrated the association
between absence of the NB at the first ges-
tational trimester with increase in the tri-
somy 21 detection rate (range = 60%–
72.9%), with a false-positive rate of 5%(13,
28,29)
. Differently from these studies, in the
present casuistic, NB evaluation demon-
strates low sensitivity for detection of chro-
mosomal abnormalities, considering that
the NB was present in all of the cases with
chromosomopathies. The results of the
present study are compatible with those
reported by Malone et al.(30), who have
obtained a sensitivity of only 7.7% for NB
absence for detecting trisomy 21, i.e., the
NB was described as present in nine of 11
fetuses with trisomy 21 (82%). A possible
explanation for the lack of sensitivity might
be the small number of cases with chromo-
somal abnormalities, with only seven fe-
tuses with trisomy 21; moreover, incidence
of abnormality in NB is variable according
to race and ethnics(31). Therefore, it would
be premature to conclude that the NB ab-
sence is a weak marker for detecting tri-
somy 21 at the first trimester of gestation.
CONCLUSION
Based on the results of the present study,
NT thickness, DV flow pattern, NB and
MA individually utilized do not demon-
strate enough sensitivity to be utilized in
the screening for chromosomopathies at the
first trimester of gestation.
Parallel evaluation of NT thickness and
DV flow pattern, one of them with positive
results, increases the sensitivity to 66.7%
for detecting chromosomal abnormalities,
with 14.29% positive predictive value. The
major benefit from this association occurs
when both results are negative in a patient,
considering that, in this case, there is a very
high probability (100%) that fetus does not
present any chromosomal abnormality.
Parallel evaluation of NT thickness, DV
flow pattern and MA presented the highest
sensitivity (100%), however with a low
positive predictive value. According to
these results, the best option for screening
for chromosomopathies at the fist gesta-
tional trimester would be the parallel com-
bination of NT thickness, DV flow pattern
and MA. In cases of MA ≥ 35 years, NT
thickness and DV flow pattern would be
evaluated. Should these results be altered,
there would be a significant evidence sug-
gesting the necessity for an invasive inves-
tigation for fetal karyotyping. In case of
alteration in only one of these results, the
couple should be offered an invasive inves-
tigation for confirming the fetal karyotype,
considering that, individually, the false-
positive rate for NT thickness is high
(16.88%) and the false-positive rate for DV
flow pattern is 8%.
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